afibrinogenemia

congenital afibrinogenemia is a rare bleeding disorder characterized by the complete absence of fibrinogen in the blood.

patients with afibrinogenemia experience prolonged bleeding from minor wounds and spontaneous bruising.

the diagnosis of afibrinogenemia requires specialized blood tests to confirm the absence of fibrinogen.

afibrinogenemia treatment typically involves replacement therapy with fibrinogen concentrate.

inherited afibrinogenemia follows an autosomal recessive pattern of inheritance.

medical research on afibrinogenemia has led to improved treatment protocols in recent years.

severe afibrinogenemia can cause life-threatening internal bleeding complications.

genetic counseling is essential for families affected by afibrinogenemia.

newborn screening can help detect afibrinogenemia early in infants.

afibrinogenemia management requires a comprehensive approach including preventive care.

the prognosis for afibrinogenemia has improved significantly with modern treatments.

scientists continue to study the genetic mutations responsible for afibrinogenemia.